Stocks / ZTS
ZTS stock forecast
ZOETIS INC · Healthcare · Drug Manufacturers - Specialty & Generic
The model's rating
Greatly Outperform
ZTS is rated Greatly Outperform as of September 29, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.
Create a free account to compare any two stocks; the numeric score is part of Premium.
ZTS is not among the 20 largest holdings published for 2026 Q4. See the portfolio
ZTS against the S&P 500
| Period | ZTS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -9.4% | -0.3% |
| 3 months | -2.9% | +2.5% |
| Year to date | -43.6% | +12.7% |
| 1 year | -51.4% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $69.83 |
| Market cap | 28.86 Billion |
| P/E (trailing 12 months) | 11.5 |
| P/S (trailing 12 months) | 3.0 |
| P/B (latest quarter) | 10.1 |
| Gross margin | 71.5% |
| Net profit margin | 27.5% |
| Return on equity | 69.3% |
| Beta | 0.6 |
As of August 6, 2026.
ZTS and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 29.53 Billion | Outperform | GEHC vs ZTS |
| MTD | METTLER TOLEDO INTERNATIONAL INC | 30.27 Billion | Greatly Underperform | MTD vs ZTS |
| CNC | CENTENE CORP | 30.69 Billion | Greatly Outperform | CNC vs ZTS |
| WST | WEST PHARMACEUTICAL SERVICES INC | 26.09 Billion | Greatly Underperform | |
| RMD | RESMED INC | 31.89 Billion | Underperform | |
| DGX | QUEST DIAGNOSTICS INC | 25.72 Billion | Underperform |
Questions
What does the Upfront Investment model say about ZTS?
The model rates ZOETIS INC (ZTS) "Greatly Outperform" as of September 29, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the ZTS rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is ZTS in the Upfront Investment model portfolio?
ZTS is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.